PANORAMIC recruitment analysis
, T., Apr 2022
Analysis of the PANORAMIC trial recuitment suggesting that if the trial shows efficacy, the NNT will be >200.
Currently there are 52 molnupiravir studies and meta-analysis shows:
| Outcome | Improvement |
|---|---|
| Mortality | 9% lower [-2‑19%] |
| Ventilation | 11% lower [-19‑34%] |
| ICU admission | 3% lower [-18‑20%] |
| Hospitalization | 0% lower [-7‑7%] |
| Cases | 24% fewer [-1‑43%] |
Lee et al., 8 Apr 2022, preprint, 1 author.